Skip to content
Broadly Epi

Broadly Epi

Epidemiology, Broadly Speaking

  • Home
  • Rent-A-Scientist
  • Software
    • Broadly Epi MMWR Archive Database
    • HSE Specialty Care Finder
  • Data Rebellion
    • Social Vulnerability Index Archive and Data Mart
  • Care Resources
    • LGBTQIA+ Health Resources
    • Health Care Affordability Resources
    • List of Resources for People Who Use Drugs
  • Blog
    • Epi Explained: Simplified Epidemiology Concepts
    • MMWR Booster: Simplified Research
    • Python Tutorials
    • R Tutorials
    • Emerging Study
    • Community Experts
  • Contact Us

Category: Epi Explained

Epi Explained: What are Sensitivity and Specificity in Epidemiology?

Posted on September 19, 2024 by Cody Micah Carmichael MPH, CPH

Epi Explained: What are Sensitivity and Specificity in Epidemiology? Quick Takeaways Sensitivity measures a test’s ability to correctly identify individuals with the disease. Specificity measures how well a test correctly

Read More
Epi Explained EpiExplained, Sensitivity, Specificity Leave a comment

Epi Explained: Understanding Biases and Errors in Epidemiology

Posted on September 12, 2024 by Cody Micah Carmichael MPH, CPH

Epi Explained: Understanding Biases and Errors in Epidemiology   Quick Takeaways What is the difference between bias and random error in epidemiology? Bias is a systematic deviation from the truth,

Read More
Epi Explained Biases, Confounding, Epi, Errors Leave a comment

Epi Explained: What is the Difference Between Epidemic, Pandemic and Endemic?

Posted on May 15, 2024 by Cody Micah Carmichael MPH, CPH

In the realm of epidemiology, the terms epidemic, pandemic, and endemic are fundamental in describing the prevalence and geographic spread of diseases. These terms, often used in public health discussions,

Read More
Epi Explained, Tutorial Endemic, Epidemic, EpiExplained, Pandemic Leave a comment

Epi Explained: Understanding Randomized Controlled Trials

Posted on May 1, 2024 by Cody Micah Carmichael MPH, CPH

Clinical trials, particularly randomized controlled trials (RCTs), are critical to  evidence-based interventions, pharmaceutical testing, and public heatlh. They provide the most reliable data on the effectiveness of treatments, interventions, and

Read More
Epi Explained, Tutorial Clinical Trials, EpiExplained, Randomized Controlled Trials Leave a comment

Epi Explained: Understanding Case-Control Study Design

Posted on April 24, 2024 by Cody Micah Carmichael MPH, CPH

Case-control studies are a cornerstone of population research, offering insights into the factors that may contribute to the occurrence of diseases or conditions. These studies are particularly invaluable in understanding

Read More
Epi Explained, Tutorial Case-Control Study, EpiExplained Leave a comment

Epi Explained: Understanding Community Trials

Posted on April 17, 2024 by Cody Micah Carmichael MPH, CPH

Nonrandomized (Community) Trials, also known as observational studies or quasi-experimental studies, are a crucial research design in epidemiology and public health. These studies provide valuable insights into the effects of

Read More
Epi Explained, Tutorial Community Trials, EpiExplained Leave a comment

Epi Explained: Understanding Cohort Studies

Posted on April 10, 2024 by Cody Micah Carmichael MPH, CPH

Cohort studies are a common study method throughout public health and intervention methods. By following groups of people who are alike in many ways but differ by a certain characteristic,

Read More
Epi Explained, Tutorial Cohort Studies, EpiExplained Leave a comment

Epi Explained: Understanding Person-Years

Posted on April 3, 2024 by Cody Micah Carmichael MPH, CPH

Person-years, often encountered in epidemiology and various forms of biomedical and public health research, stands as a pivotal concept that enables researchers to quantify the amount of time that study

Read More
Epi Explained EpiExplained, Person-Years 1 Comment

Epi Explained: Understanding SIR Models

Posted on March 27, 2024 by Cody Micah Carmichael MPH, CPH

The Susceptible-Infectious-Recovered (SIR) model stands as a cornerstone in epidemic modeling, providing a mathematical framework to describe the spread of infectious diseases within a population. This model not only encapsulates

Read More
Epi Explained EpiExplained, SIR Model Leave a comment

Epi Explained: Understanding Relative Risk

Posted on March 20, 2024 by Cody Micah Carmichael MPH, CPH

Relative risk (RR), also known as risk ratio, is a cornerstone concept in epidemiology and public health, offering insight into the strength of the association between an exposure and an

Read More
Epi Explained EpiExplained, Relative Risk Leave a comment
  • ← Previous
  • 1
  • 2
  • 3
  • Next →

Search

Categories

Recent Posts

  • Community Experts Issue 3: Rowan Odom’s Story – Living with an Undiagnosed Chronic Illness February 1, 2025
  • MMWR Booster for: Use of Ebola Vaccine: Expansion of Recommendations of the Advisory Committee on Immunization Practices To Include Two Additional Populations — United States, 2021 / February 25, 2022 / 71(8);290–292 January 11, 2025
  • MMWR Booster for: Screening Programs for SARS-CoV-2 Infections on a University Campus — Austin, Texas, September 30–November 30, 2020 / September 3, 2021 / 70(35);1201–1205 January 10, 2025
  • MMWR Booster for: Results from a Test-to-Release from Isolation Strategy Among Fully Vaccinated National Football League Players and Staff Members with COVID-19 — United States, December 14–19, 2021 / February 25, 2022 / 71(8);299–305 January 10, 2025
  • MMWR Booster for: Multiple Variants of SARS-CoV-2 in a University Outbreak After Spring Break — Chicago, Illinois, March–May 2021 / September 3, 2021 / 70(35);1195–1200 January 9, 2025
  • MMWR Booster for: Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5–17 Years — VISION Network, 10 States, April 2021–January 2022 / March 4, 2022 / 71(9);352–358 January 9, 2025
  • MMWR Booster for: Interim Guidance: 4-Month Rifapentine-Moxifloxacin Regimen for the Treatment of Drug-Susceptible Pulmonary Tuberculosis — United States, 2022 / February 25, 2022 / 71(8);285–289 January 8, 2025
  • MMWR Booster for: Evaluation of Syndromic Surveillance Data for Studying Harmful Algal Bloom-Associated Illnesses — United States, 2017–2019 / September 3, 2021 / 70(35);1191–1194 January 8, 2025
  • MMWR Booster for: Safety Monitoring of COVID-19 Vaccine Booster Doses Among Persons Aged 12–17 Years — United States, December 9, 2021–February 20, 2022 / March 4, 2022 / 71(9);347–351 January 7, 2025
  • MMWR Booster for: National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2020 / September 3, 2021 / 70(35);1183–1190 January 7, 2025
  • Github
  • BlueSky
  • Threads
  • LinkedIn